[Theranica in PR Newswire] Theranica enters into agreement with Dr. Reddy’s for commercializing Nerivio® in India

[Theranica in PR Newswire] Theranica enters into agreement with Dr. Reddy’s for commercializing Nerivio® in India

Source Node: 1892556

NETANYA, Israel, Jan. 10, 2023 /PRNewswire/ — Theranica, a prescribed digital therapeutics company developing advanced neuromodulation devices for migraine and other pain conditions, today announced a strategic license and supply agreement with Dr. Reddy’s Laboratories Ltd., a global pharmaceutical company, for the exclusive marketing and distribution of FDA-approved Nerivio® in India, subject to completion of the regulatory approval process in India.

Read more here.

Time Stamp:

More from OurCrowd Blog